AviadoBio: Bold and Courageous

Published: Jan. 17, 2023, 9 a.m.

AviadoBio CEO Lisa Deschamps discusses the unique approach her team is taking to deliver a therapeutic for frontotemporal dementia and other neurodegenerative diseases.